Discontinued — last reported Q1 '24
Other
2031
Biogen 2031 increased by 7.7% to $700.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $700.00M to $700.00M. Over 3 years (FY 2020 to FY 2023), 2031 shows an upward trend with a 31.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2024
How to read this metric
Lower projected expenses in later years indicate the eventual expiration of amortization schedules for older acquisitions.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2031. It is part of t...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_5777a7Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00M | $180.00M | $180.00M | $165.00M | $165.00M | $165.00M | $165.00M | $165.00M | $165.00M | $445.00M | $495.00M | $715.00M | $720.00M | $655.00M | $700.00M | $700.00M | $650.00M | $700.00M |
| QoQ Change | — | -10.0% | +0.0% | -8.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +169.7% | +11.2% | +44.4% | +0.7% | -9.0% | +6.9% | +0.0% | -7.1% | +7.7% |
| YoY Change | — | — | — | — | -17.5% | -8.3% | -8.3% | +0.0% | +0.0% | +169.7% | +200.0% | +333.3% | +336.4% | +47.2% | -2.1% | -2.8% | -0.8% | +0.0% |
Range$165.00M – $720.00M
CAGR+34.3%
Avg YoY Growth+74.8%
Median YoY Growth+0.0%
2031 at Other Companies
Frequently Asked Questions
- What is Biogen's 2031?
- Biogen (BIIB) reported 2031 of $700.00M in Q1 2026.
- How has Biogen's 2031 changed year-over-year?
- Biogen's 2031 decreased by 0.0% year-over-year, from $700.00M to $700.00M.
- What is the long-term trend for Biogen's 2031?
- Over 3 years (2020 to 2023), Biogen's 2031 has grown at a 31.0% compound annual growth rate (CAGR), from $220.00M to $495.00M.
- What does 2031 mean?
- The expected non-cash expense for acquired intangible assets in the year 2031.